Pyrimidine degradation and β-alanine
Cytosine, uracil and thymine are broken down to soluble products such as β-alanine; one enzyme of this route decides whether 5-fluorouracil is safe.
Key facts
- Cytosine is deaminated to uracil; dihydropyrimidine dehydrogenase (DPD) then reduces uracil and thymine, the first step and the one that sets the pace.
- The ring is opened and split: uracil ends as β-alanine, CO₂ and ammonia; thymine ends as β-aminoisobutyrate.
- These end products are water-soluble, so unlike uric acid from purines they do not crystallise or cause gout.
- β-Alanine is used to make carnosine (a buffer dipeptide in muscle) and is part of pantothenic acid and so of coenzyme A.
- β-Aminoisobutyrate is excreted in urine or converted to succinyl-CoA.
In detail
- Urinary β-aminoisobutyrate rises when DNA turnover is high (leukaemia, radiotherapy, chemotherapy); some healthy people are genetic high excretors.
- β-Alanine can also be broken down to acetyl-CoA by way of malonate semialdehyde.
- Defects of the later enzymes (dihydropyrimidinase, β-ureidopropionase) are rare and can cause neurological problems.
- Also called
- Pyrimidine catabolism, β-Aminoisobutyric acid
Clinical notes
- Dihydropyrimidine dehydrogenase deficiency causes severe, sometimes fatal toxicity from 5-fluorouracil and capecitabine, which this enzyme normally clears; DPYD testing before treatment is recommended in many countries.
- Pyrimidine breakdown products need no special treatment in tumour lysis; the uric acid from purines is what causes kidney injury.
Test yourself
Think of the answer, then tap the question to see it.
Which enzyme is rate-limiting in pyrimidine degradation, and why does it matter in oncology?
Dihydropyrimidine dehydrogenase (DPD); its deficiency makes 5-fluorouracil and capecitabine highly toxic.
Why does pyrimidine breakdown not cause gout?
Its end products (β-alanine, β-aminoisobutyrate) are water-soluble, unlike uric acid.
Which two molecules contain β-alanine?
Carnosine and pantothenic acid (and so coenzyme A).
Connections
Educational information, not medical advice. For any symptom, see a health professional.
Sources: Pyrimidine catabolism (Reactome, 2026); Dihydropyrimidine dehydrogenase deficiency: MedlinePlus Genetics (MedlinePlus, US National Library of Medicine, 2026); Beta-ureidopropionase deficiency: MedlinePlus Genetics (MedlinePlus, US National Library of Medicine, 2026).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.